SARS-like WIV1-CoV poised for human emergence

Cited by (420)

Items 401–420 of 420

1. COMPARATIVE CHARACTERISTICS OF THE ACCUMULATION OF DIFFERENT VARIANTS OF THE SARS-COV-2 VIRUS (WUHAN, DELTA, OMICRON) IN THE ORGANS OF MODEL ANIMALS
   А. С. Чернов, V.A. Kazakov, Irina S. Gogleva, Савенко Сергей Вадимович, Щукина Вероника Николаевна, S. Ya. Loginova, Sergey V. Borisevich, Ivan V. Smirnov, Georgii B. Telegin, Alexey A. Belogurov · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
2. Animal Models for Human-Pathogenic Coronavirus and Animal Coronavirus Research
   Fenglian Xiao, Jincheng Hu, Minsheng Xu, Di Wang, Xiaoyan Shen, Hua Zhang, Jie Miao, Haodong Cai, Jihui Wang, Yaqing Liu et al. · 2025 · Viruses
3. A Perspective Review on Animal Coronaviruses: From Infection Insights to Preventive Measures and Antiviral Advancements
   Tanvi Tanvi, Rajat Goyal, Rupesh Kumar Gautam, Kashish Wilson, Kajal Garg, Tanmay Sharma, Sumeet Gupta, Sachin Kumar Singh, Haider Ali, Gaurav Gupta et al. · 2025 · Coronaviruses
4. Development of a Recombinant Single-Cycle Influenza Viral Vector as an Intranasal Vaccine against SARS-CoV-2 and SARS-like Betacoronaviruses
   Jonathan Munro, Diana Melnyk, Madeeha Afzal, Lisa Schimanski, Alexander A. Cohen, Jennifer R. Keeffe, Pamela J. Björkman, William James, Alain Townsend, Tiong Kit Tan · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
5. Characterization and immunogenicity of nanoparticle vaccines based on Clade 2 and Clade 3 sarbecovirus S2 proteins
   Peter Halfmann, Raj S. Patel, Augustine Duffy, Tong Wang, Atsuhiro Yasuhara, Kayla Carneal, Annika Singh, Carmen Rai, Patrick C. Wilson, Yoshihiro Kawaoka et al. · 2025 · npj Vaccines
6. A neutralizing human antibody induces movement of the HCoV-229E receptor binding domain
   Mera F. Liccione, Trevor Scobey, Heather M. Froggatt, Camryn Pajon, Boyd L. Yount, Qi Yin, Taylor N. Spence, Emmanuel B. Walter, Kevin O. Saunders, Robert J. Edwards et al. · 2025 · Communications Biology
7. Pathomorphological Features of Lung Damage Caused by Infection with Various Variants of SARS-CoV-2 in Humanized Model Animals
   A. S. Chernov, V. A. Kazakov, Irina S. Gogleva, Fedor A. Meshcheryakov, Anna A. Kudriaeva, А. П. Богачук, И. В. Смирнов, Georgii B. Telegin, А А Белогуров, А.Г. Габибов · 2026 · Doklady Biochemistry and Biophysics
8. Immunogenic relationship mapping supports a minimal-set trivalent vaccine strategy for broad sarbecovirus protection
   Yeqing Sun, Ziqi Cheng, Xi Wu, Yunbo Bai, Lina Zhao, Hongyu Xiang, Weijin Huang, Jianhui Nie · 2026 · Signal Transduction and Targeted Therapy
9. Cryo-EM structure of locked spike glycoprotein from bat SARS-like coronavirus WIV1, molecular dynamics and biophysics across host range
   Chuan Liu, Jingjing Zheng, Yuhan Wang, F. Beck, István Nagy, Stefan Bohn, Jürgen M. Plitzko, Wolfgang P. Baumeister, Xiaoxiao Zhang, Liping Sun et al. · 2026 · Proceedings of the National Academy of Sciences
10. Molecular diversity and evolutionary dynamics of Nipah virus: implications for surveillance and control
    Amos Dangana, Adesuyi Ayodeji Omoare, Nanpon Miri, Bwede Eugene Bwede, Mangpin Leviticus Dansura, Villeng Felix Gagari, Nkiruka Lynda Uzoebo, James Christopher Avong, John Okoh, Olakitan Jinadu et al. · 2026 · International Journal of Community Medicine and Public Health
11. Exploration of autophagy modulation in cancer and infectious diseases
    Eloïne Bestion · 2021 · theses.fr (ABES)
12. Analyse du cycle du SARS-CoV-2 en modèle cellulaire par microscopie électronique à transmission
    Sébastien Eymieux · 2023
13. Evaluating the immunogenicity of clade 2 and clade 3 sarbecovirus spike protein nanoparticle vaccines in Syrian hamsters
    Peter Halfmann, Augustine Duffy, Tong Wang, Yoshihiro Kawaoka, Ravi S. Kane · 2026 · Vaccine
14. Non-Covalent 3CLpro Inhibitors with Cross-Lineage Activity Against Zoonotic Betacoronavirus
    Ruixi Yan, Na Luo, Zhao Gao, Mengfei Qian, Jin Wu, Gang Zou, Chunguang Wu, Shuai Yuan, Yan Li · 2026 · Zoonotic Diseases
15. A phage display library to dissect antibody responses to human coronavirus spike proteins
    Louis J. Taylor, Thiagarajan Venkataraman, Matthew B. Frieman · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
16. The Alleged Role of Bats in Successive Global Pandemics and Its Implications for Conservation
    Alfonso Balmorí, Alfonso Balmori‐de la Puente · 2026 · Conservation
17. Vaccine-Associated Enhanced Respiratory Disease: From Animal Models to Human Health
    Jacob A. Dillard, Reina A. Saldivar, Mark T. Heise, Victoria Kate Baxter · 2026 · Vaccines
18. Host Factor Experiment (SM014-R)
    J. Craig Venter Institute, University of Chicago · 2014 · Virus Pathogen Resource
19. BindingDB Entry 8944: An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.
    BindingDB · 2020 · UC San Diego
20. Chemoenzymatic Synthesis of 6‐Sulfo Sialyl Lewis x Containing Glycans to Probe the Receptor Specificity of MERS Coronavirus
    Yunfei Wu, Anne L. M. Kimpel, Jacobus P. van Trijp, Elif Uslu, Gaël M. Vos, Luca Unione, Robert P. de Vries, Geert‐Jan Boons · 2026 · Angewandte Chemie